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Abstract
Background: Subject recruitment for medical research is challenging. Slow patient accrual leads to increased costs
and delays in treatment advances. Researchers need reliable tools to manage and predict the accrual rate. The
previously developed Bayesian method integrates researchers’ experience on former trials and data from an
ongoing study, providing a reliable prediction of accrual rate for clinical studies.
Methods: In this paper, we present a user-friendly graphical user interface program developed in R. A closed-form
solution for the total subjects that can be recruited within a fixed time is derived. We also present a built-in Android
system using Java for web browsers and mobile devices.
Results: Using the accrual software, we re-evaluated the Veteran Affairs Cooperative Studies Program 558— ROBOTICS study.
The application of the software in monitoring and management of recruitment is illustrated for different stages of the trial.
Conclusions: This developed accrual software provides a more convenient platform for estimation and prediction of the
accrual process.
Keywords: Bayesian methods, Smartphone application, Statistical software, Subject accrual
Background
Subject recruitment is critical and often very challenging
in clinical research studies. Investigators frequently over-
estimate the pool of available subjects and underestimate
the time needed to achieve the proposed sample size for
their studies. This is known as Lasagna’s law [1] and as
Muench’s third law [2]. Studies have shown that more
than 80 % of clinical trial studies ran longer than their
original accrual time goals [3]. A delay in study partici-
pant recruitment or an insufficient sample size can have
serious deleterious consequences. Extending the recruit-
ment time frame leads to increased costs, while a delay
in study completion can lower the scientific impact or
relevance. If the proposed sample size is not achieved,
the study may be seriously underpowered. Therefore, it
is important for researchers to monitor the accrual rate
closely throughout the enrollment period of a study.
A number of studies have been published to model
and predict patient accrual process. Both Barnard et al.
[4] and Zhang and Long [5] recently reviewed prediction
methods. The available accrual models include uncon-
ditional and conditional model, Poisson-based models,
Brownian-motion-based models, and Bayesian models
[4, 5]. Both Barnard et al. [4] and Zhang and Long [5]
addressed the Bayesian methods developed by Gajewski
et al. [6]. The Bayesian approach can utilize researchers’
previous experience from similar studies or clinical opin-
ion and incorporate them as prior knowledge. When ac-
tual accrual data are available, the predictive distribution
of the accrual data becomes the weighted average of the
prior distribution and the actual observed data. As more
data are collected, the weighting of the current observed
data will increase while the weighting of prior informa-
tion will decrease [6]. Such an approach provides an ef-
fective assessment of the accrual process.
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Developing statistical methods are always important;
however, providing reliable tools should also be a priority
[7]. Typically, a clinical trial study team consists of clini-
cians, biostatisticians, project managers, software pro-
grammers, etc. Apart from biostatisticians, the majority of
the other team members might not be familiar with the
Bayesian framework, and it is challenging for them to use
the algorithm for accrual prediction directly. Therefore, a
simple and easy-to-use interface is in demand. One of the
most commonly used and convenient approaches is to
adopt the Bayesian computation into R, which is a free
software environment for statistical analysis [8].
Although R and its packages are very popular in the
area of statistics, many clinicians and project managers
might not be familiar with them. A web calculator plus a
smartphone application will make the tool more user-
friendly and more convenient.
In this study, we translate our prediction model into
an R accrual package. To make it easier, we applied the
graphical user interface options in R, which only require
researchers to input the original design information and
the updated accrual data using simple point-and-click
methods [8, 9]. The accrual package has been promoted
on the RCRAN and is ready to be used by both statisti-
cians and clinical researchers in evaluating and monitor-
ing their subject accrual. We also derived a closed-form
solution for the posterior prediction of the remaining
subjects that can be recruited within a fixed time period,
where the subject count is modeled as negative binomial.
The credible interval for patient recruitment then can be
calculated using a normal approximation for negative bi-
nomial. In a recent study [10], we also derived a closed-
form solution for the posterior prediction of accrual with
an inverse beta distribution. Based on the closed form,
we developed a web browser and an Android version of
the accrual calculator, which can be easily installed and
used by a smartphone carrier.
The potential use of the accrual software for manage-
ment and evaluation of the recruitment is discussed
using the existing clinical studies conducted by the De-
partment of Veterans Affairs Cooperative Studies Pro-
gram Coordinating Center at West Haven, Connecticut
[11, 12]. The application of the software is discussed in
three aspects: (1) initial planning of the study, (2) in-
terim review of the recruitment progress, and (3) evalu-
ation of the site performance.
Methods
The general method and the closed form
In a clinical study, assume that the investigator needs to
recruit n subjects. Based on previous trial experience
and the potential available patient population, the inves-
tigator plans to finish recruitment in T days. Suppose
that the trial starts at time t0, and that new patients
enter the study sequentially, at t1, t2, tm … Then the
waiting time for each successive patient is calculated as
wi ¼ ti − ti−1;
and wi is assumed to follow an exponential distribution,
that is
wi∼expðθÞ;
in which θ represents the average accrual time for the ith
subject. To apply the Bayesian constant accrual model [6],
we assume that the prior distribution of θ is inverse
gamma, that is
θ∼IGðnP; TPÞ;
where P is defined as the investigator’s confidence of fin-
ishing the trial in the original planned time, measured on
a 0–1 scale [6]. In the process of a trial, suppose that m
subjects have been collected within time Tm(Tm = ∑i= 1
m wi).
Then the posterior distribution for θ is
f θjm;Tmð Þ ¼ TP þ Tmð Þ
nPþm




Using R, the Bayesian method for simple accrual [6] can
easily be conducted using simulations. To speed up the
calculation, it is better to develop a closed-form solution
that can be used in Java. For fixed T, assuming that the







































¼ ðTP þ TmÞ
nPþmðT−TmÞηΓðnP þmþ ηÞ
ðTP þ TÞnPþmþηΓðnP þmÞη! : ð3Þ
Define
p ¼ TP þ Tm
TP þ T ð4Þ
and
r ¼ nP þm:
Then
ηð Þ ¼ pr 1−pð Þη Γ rþ ηð Þ
Γ rð Þη! :
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This formula shows that the posterior predictive distri-
bution of η is negative binomial:
NB(r,p).
As discussed by Jiang et al. [10], the closed form of the
time frame of accrual shows an inverse beta distribution.
We can use a normal approximation approach (Additional
file 1), which can greatly accelerate the speed of calcula-
tion. The normal approximation works well if r is large
and p is neither too small nor too large. To meet the re-
quirement, we recommend that at the very beginning of
the trial, when m and Tm are zero or small, the prior P
should be relatively large (e.g., 0.5). After the trial starts,
for example, when Tm ¼ T2 , p will be in the range of 0.5
and 0.75. The value of prior P will almost have no effect
on the normal approximation.
The derivation of the closed form also makes it pos-
sible to adopt the Bayesian constant accrual model in
Java, which lacks built-in sampling algorithms.
R accrual package, web-based calculator and smartphone
applications
The objective of the package development is to adopt
the Bayesian computation into R, which is ‘a free soft-
ware environment for statistical computing and graphics’
[8]. As shown in Fig. 1, the entire Bayesian prediction
model computation is in the background [6]. The design
information includes the total time proposed for recruit-
ment and the total sample size needed for the study,
which are typically included in the protocol and required
by institutional review boards. The developed software
has three major functions: (a) to provide the estimate of
the total number of subjects that the trial will have re-
cruited within the planned time frame, (b) to provide the
time frame that the trial will successfully recruit enough
number of subjects, and (c) to produce diagnostic panel
plots of the actual accrual data, such as the cumulative ac-
crual plot and the distribution of the accrual etc.
The developed R accrual 1.1 package has been pro-
moted to R (> = 2.8.0) and is available for download from
the Comprehensive R Archive Network. It includes an
example data set, three major functions (described next),
and a graphical user interface that provides a menu-
driven access to these functions in R (Fig. 2). These
three major R functions are accrual.n, accrual.T and
accrual.plots. The function accrual.n calculates the pre-
diction of the number of patients to be recruited in a
fixed time. The function accrual.T predicts the time to
reach targeted sample size. The function accrual.plots
provides a panel of plots for data diagnostics. The
accrual.gui provides an interface for the users to choose
any of the three options as needed. The supplementary
document provides a full menu on how to use the R
package and how to interpret the results with examples.
As discussed here and in Jiang el al. [10], the closed form
of the time frame of accrual is inverse beta, and the
closed-form solution of the remaining subjects that can be
recruited in a fixed time is distributed as negative binomial.
Using a normal approximation for both of the above distri-
butions can greatly accelerate the speed of calculation.
Therefore, the normal approximation algorithm is
adopted in Java and used for the accrual estimations.
Our group developed a web-based accrual software using
Java. An example of the use of this web calculator is
shown in Fig. 3a. The link to the software can be found at
http://biostat-pts.kumc.edu/velos/RPackages/Home.html.
With the development and widespread use of smart-
phones, the accrual smartphone application, compared
with R packages or web-based application, can make the
tool more user-friendly and convenient for clinical re-
searchers. Using a closed-form solution for Bayesian ac-
crual model and normal approximation, the methods are
adopted into an Android application using Java. Figure 3b
shows the use of an Android phone in the process of ac-
crual monitoring.
Results
Here we provide specific examples to illustrate how the
accrual software can be used in the evaluation or man-
agement of a clinical trial. The ROBOTICS study was a
randomized, multicenter, clinical trial to assess robot-
assisted therapy for neuro-rehabilitation in chronic stroke
patients [11]. The prediction of patient recruitment can
be used at different stages of the study or for different
purposes, such as study planning, interim review of the
recruitment progress, and evaluation of the site
performance.Fig. 1 The flowchart of the accrual software
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Initial planning of the study
The target total sample size for ROBOTICS was 158, to
achieve 90 % power of the protocol-defined effect size and
variance assumptions estimated from the literature. Based
on the investigators’ experience, the number of participat-
ing sites, and database estimates of the available study
population, it was proposed to achieve the target sample
size recruitment in 24 months. Using the accrual software,
it is easy to project the recruitment with consideration for
the randomness and uncertainty in the process. Figure 4
shows that the 95 % credible interval for patient accrual in
24 months is (118, 201). The time to recruit 158 patients
could be between 18.5 months and 31.7 months, if one
chooses P = 0.5. The graph and output can be used as a
reference and guide for the investigator to plan the study,
especially to estimate study budgets. As the total accrual
in 24 months could be as low as 118, and the time to
reach the full sample size could be as long as 31.7 months,
the investigator would make some alternative plans, in
case these extreme situations happens.
Interim review of the recruitment progress
During the process of the clinical study, recruitment is
almost always closely monitored. Usually, patient enroll-
ments by participating site are summarized and reported
on a weekly or monthly basis. The accrual software can be
used for prediction at any time during the trial. The re-
sults will help investigators, sponsors, and oversight com-
mittees objectively evaluate the progress of the study.
Figure 5 shows the projected accrual of patients at
24 months based on the current data using the software
with P = 0.5. The figure clearly shows that, starting from
months 13 it is highly probable that the study will not be
able to recruit 158 subjects within the study time frame
given the current recruitment process. The investigator
should consider strategies to increase the accrual rate,
such as adding one more study center, or changing the
study protocols. The final recruitment ended up as 126 in
24 months, which was within the credible interval of all
predictions shown in Fig. 5.
Overall, if the predicted accrual rate is so slow that it
threatens the ability to achieve the proposed sample size
and increases the trial duration of a study, this objective
assessment will allow the study sponsor or data monitor-
ing committees [3] to suggest mid-course corrections in
the trial, such as adding additional centers to a multicen-
ter study, hiring additional study coordinators to broaden
the search for volunteers, or updating the inclusion or
exclusion criteria. Conversely, the method can also pre-
vent a researcher from overreacting to slow accrual at the
Fig. 2 The main menu of the R accrual package with three options
Fig. 3 (a) An example of the use of accrual web-based software to calculate the number of patients can be recruited when one-quarter of the
projected subjects has been recruited. (b) Use of the accrual smartphone application
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beginning of the study. If the accrual is faster than
planned, the prediction model can provide an estimated
closure date to avoid unnecessary patient recruitment.
Evaluation of the site performance
The accrual software is designed for single-site re-
cruitment. However, most clinical studies are currently
conducted at several sites. In the case of ROBOTICS, the
study was conducted at four sites. The potential patient
populations for each site and the experiences of site inves-
tigators are often different at each participating site. In the
monitoring and management of recruitment in a multi-
center trial, it is critical to evaluate the performance of
each participating site separately. The sites that are signifi-
cantly slow or inefficient in enrollment should have fo-
cused attention to try and improve the situation, and if no
improvement is made during a ‘probation’ period, the pru-
dent response can be to end that site’s participation in the
study.
Figure 6a and 6b show the predicted average accrual
for the ROBOTICS study when the trial started recruit-
ment for 6 months and 12 months. The traditional and
easiest method to evaluate the performance of an indi-
vidual site is to use the red line, which is the investiga-
tors’ original expected recruitment, as a reference for
each site by assuming that the accrual is constant with-
out variations at each time points. As shown in Figure 6,
only one site at the beginning of the trial is exceeding or
even meeting the expectation, while the other three sites
are below the target reference line throughout the trial.
When compared with the projected recruitment target
using accrual software, three of the sites fall within the
95 % credible interval, with only one site at or below the
lower end of the confidence limits (the bottom line). As
Fig. 4 The R accrual package can be used at the beginning of the clinical trial to calculate the number of patients that can be recruited. The red
line is the investigators’ original expected recruitment. The white line and gray tunnel are the projected accrual with 95 % credible interval
Fig. 5 Projected patient recruitment with 95 % credible interval for
the Robot study at each month: the red line indicates the proposed
sample size n = 158 and the blue line is final recruitment n = 126
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the Bayesian methods utilized the investigators’ original
expectation and current recruitment data for all the
sites, it is more reasonable in the evaluation of site per-
formance compared with the traditional method.
The accrual software also applies to larger studies.
Figure 6c and 6d display the recruitment process of an-
other clinical trial study (TEAM-AD), a double-blind,
placebo-controlled, randomized, clinical trial to assess
the efficacy of α-tocopherol and memantine in Alzhei-
mer’s disease [12]. The target sample size for the
TEAM-AD was originally 840 patients, to be recruited
from 14 sites over three years. At 12 months and
24 months, about 10 sites do not seem to meet the re-
cruitment target when using traditional methods (red
reference line). The results by Bayesian software show
that the majority of sites perform in the 95 % confidence
region, with approximately six sites well below expect-
ation. Like the ROBOTICS study, the Bayesian method
is more reasonable in evaluating site performance using
both expected recruitment and current accrual data.
Overall, the accrual software helps to recognize low per-
formance. Early monitoring and identification of low
performing sites will help study oversight committees
make well informed decisions and work out efficient
strategies to improve the enrollment of each site, which
in turn improve the management of recruitment for the
entire study.
Discussion
Development of software can be as important as the de-
velopment of novel statistical methods [7]. In this paper,
we evaluated the completed ROBOTICS and the
TEAM-AD clinical trials using the proposed software by
demonstrating that the recruitment tool can be used at
all stages of the study.
The R accrual packages, both the web-based and the
smartphone application for patient accrual, are based on
the assumption that the accrual rate is constant. Based
on our previous findings [13], the assumption for con-
stant accrual is reasonable and generally holds, especially
for small single-site clinical trials conducted in an aca-
demic research institute. The performance of the con-
stant accrual model has also been evaluated via real
clinical studies and extensive simulation studies [10].
The general finding is that when the accrual is on target,
a strong prior (a relative larger P, such as P = 0.5) per-
forms better. When the accrual is off target, a weak prior
(a smaller P, such as P = 0.01) works better in prediction.
The constant accrual model performs well when the ac-
crual rates vary slightly, for example, by being more slow
Fig. 6 Evaluation of the patient recruitment for each of the four sites in the ROBOTICS study with enrollment data from (a) the first 6 months (b)
the first 12 months, and the TEAM-AD study with enrollment data from (c) the first 12 months and (d) the first 24 months. The red lines are the
investigators’ original expected recruitment for each site. The white lines and gray tunnels are the averages of recruitment for the four sites with
projected accrual with 95 % credible interval. The black lines are the accumulated patient enrollment for each of the 14 sites
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at the beginning of a trial. Even in some situations where
the model does not predict the completion time cor-
rectly, it can still recognize early that an accrual is off
target.
In the constant accrual model, specification of the
prior, P is critical. In general, if the investigators have
rich experience in the study and follow the definition of
P correctly to choose a reasonable value for P, it will be
beneficial to model prediction. As illustrated in the
simulation study, when the accrual is on target and the
investigators have higher confidence, they tend to choose
a larger P, which will lead to better prediction. When the
accrual is slow, the investigators lack confidence and are
more likely to choose a smaller P, which will also lead to
a better prediction. In some situations where the users
have a hard time specifying P, we suggest P =0.1 as a rea-
sonable value to start with.
Overall, the software is robust when the assumption is
only slightly violated [10, 13]. However, it should still be
used with caution and it is worth examining the data
distribution to check whether the assumptions are vio-
lated or not. In the current software, we only have diag-
nostic plots for data distribution. In the future, we will
add more model diagnostic methods, such as testing the
assumption for independence and sensitivity analysis
[13]. We assume that the waiting time is distributed ex-
ponentially. A more general approach in the future is to
model the waiting time using a Weibull distribution. For
obvious non-constant accrual studies, we are working on
linear piecewise regression models, where the accrual is
divided into a certain number of stages. It has been
shown that it is critical to choose the prior, P, in the pre-
diction of accrual. To avoid poor choices of P, we have
introduced adaptive priors, an accelerated prior and a
hedging prior, which are shown to be more robust than
a subjective prior when the constant accrual assumption
is violated. The accrual software with these new priors
will be available soon. In addition, the current accrual
software is only designed for single-site clinical studies
or the review of a single site. An upgrade version of the
accrual software, which includes prediction for multisite
recruitment, is under development.
Conclusions
In summary, we present an R accrual package, and a
built-in Android system using Java for web browser and
mobile devices based on a previously developed Bayesian
constant accrual model. The accrual software provides a
convenient platform for researchers in the evaluation of
the accrual process in clinical studies. We use specific
examples to illustrate how the software can be used, as
well as its strength and limitations. Future planned work
will involve continued assessment of our assumptions.
We also plan to build new models for both single-site
and multisite clinical trials and to translate these
methods into easy-to-use software for monitoring clin-
ical trials.
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